This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1979 Jun 16;1(8129):1297-8.

doi: 10.1016/s0140-6736(79)92259-1.

Oral prostaglandin E2 in pulmonary atresia

J Y Coe, E D Silove

PMID: 87761
DOI: 10.1016/s0140-6736(79)92259-1

Oral prostaglandin E2 in pulmonary atresia

J Y Coe et al. Lancet. 1979.

. 1979 Jun 16;1(8129):1297-8.

doi: 10.1016/s0140-6736(79)92259-1.

Authors

J Y Coe, E D Silove

PMID: 87761
DOI: 10.1016/s0140-6736(79)92259-1

No abstract available

PubMed Disclaimer

Similar articles

Pulmonary arterial structure in pulmonary atresia after prostaglandin E2 administration.
Haworth SG, Silove ED. Haworth SG, et al. Br Heart J. 1981 Mar;45(3):311-6. doi: 10.1136/hrt.45.3.311. Br Heart J. 1981. PMID: 7470344 Free PMC article.
Oral prostaglandin E2 in pulmonary atresia.
Dansky R, Levin SE. Dansky R, et al. S Afr Med J. 1981 Nov 28;60(22):842. S Afr Med J. 1981. PMID: 7302754 No abstract available.
Oral prostaglandin E in the management of pulmonary atresia. A case report.
Human DG, Fraser CB. Human DG, et al. S Afr Med J. 1982 Dec 18;62(26):1001-2. S Afr Med J. 1982. PMID: 7147139 No abstract available.
Advances in the treatment of pulmonary atresia with intact ventricular septum: palliative and definitive repair.
Laks H, Billingsley AM. Laks H, et al. Cardiol Clin. 1989 May;7(2):387-98. Cardiol Clin. 1989. PMID: 2471593 Review.
[Branching of the aorta and the pulmonary artery from the right heart ventricle].
Aleksi-Meskhishvili VV, Podzolkov VP. Aleksi-Meskhishvili VV, et al. Kardiologiia. 1976 Mar;16(3):146-55. Kardiologiia. 1976. PMID: 799179 Review. Russian. No abstract available.

See all similar articles

Cited by

Evaluation of oral and low dose intravenous prostaglandin E2 in management of ductus dependent congenital heart disease.
Silove ED, Roberts DG, de Giovanni JV. Silove ED, et al. Arch Dis Child. 1985 Nov;60(11):1025-30. doi: 10.1136/adc.60.11.1025. Arch Dis Child. 1985. PMID: 3865636 Free PMC article.
Pulmonary arterial structure in pulmonary atresia after prostaglandin E2 administration.
Haworth SG, Silove ED. Haworth SG, et al. Br Heart J. 1981 Mar;45(3):311-6. doi: 10.1136/hrt.45.3.311. Br Heart J. 1981. PMID: 7470344 Free PMC article.
Reversibility of cortical hyperostosis following long-term prostaglandin E1 therapy in infants with ductus-dependent congenital heart disease.
Høst A, Halken S, Andersen PE Jr. Høst A, et al. Pediatr Radiol. 1988;18(2):149-53. doi: 10.1007/BF02387559. Pediatr Radiol. 1988. PMID: 3281113
Administration of E-type prostaglandins in ductus-dependent congenital heart disease.
Silove ED. Silove ED. Pediatr Cardiol. 1982;2(4):303-5. doi: 10.1007/BF02426977. Pediatr Cardiol. 1982. PMID: 6956847 No abstract available.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science